L’Oréal settled with four women during the first hair relaxer cancer trial, but the deal only covers those plaintiffs. More than 12,700 cases are in the separate federal hair relaxer MDL, and the settlement doesn't touch those. The real test is the first bellwether trial, set for September 2027.
People involved in the November 13 New Orleans riverboat collision may face psychological injuries long after the rescue. PTSD and other emotional effects can complicate recovery and raise questions about legal rights under maritime law.
Women pursuing Depo-Provera brain tumor lawsuits face a November 30 settlement registration deadline, but other legal options still remain for many. Those affected should know who may qualify, when payments could begin, and the legal risks facing women who don't register for the settlement.
The FDA is requiring new warnings about rare, potentially permanent vision loss associated with Ozempic and other GLP-1 medications. The order has raised important questions about NAION risks, patient safety, and the potential impact on ongoing lawsuits.
Workers who cut, grind, and polish engineered stone countertops face serious health risks from silica dust exposure. Research raises concerns about workplace safety, undiagnosed silicosis, and potential legal claims.
Recent healthcare data breaches involving a North Texas company, a major insurer, and a national laboratory have raised concerns about patient privacy. Learn what Texas law requires, how to protect your medical information, and when a data breach may lead to legal action.
3M has agreed to pay billions of dollars to resolve 115,000+ PFAS firefighting foam injury claims. But questions remain about who qualifies, how long compensation will take, and whether people diagnosed with PFAS-related illnesses in the future will be covered.
Louisiana has added three kratom-related compounds to Schedule I as federal regulators examine potent opioid substances in these products. The new restrictions also raise questions about product ingredients, consumer warnings, and potential liability.
There are specific diagnostic testing requirements for patients alleging Ozempic and other GLP-1 drugs caused gastroparesis. Learn accepted tests, why timing matters, what's required for other GI injuries, and how missing medical evidence could affect compensation.
The EPA has postponed proposed regulations addressing asbestos left in older buildings until 2027, drawing criticism from safety advocates. Here's what the delay means for Texans, existing protections, and potential exposure.
Sandoz will pay $400 million to settle generic drug price-fixing allegations with 48 states. Americans who bought certain generic medications may be eligible for compensation. Here's how to file a claim and what the settlement may mean for the future cost of prescription drugs.
On September 12, another 28 municipalities and fire departments sued 3M, DuPont, and Honeywell, alleging PFAS in firefighter turnout gear contaminated their facilities and equipment. Filed into the existing MDL, the case is separate from the more than 15,000+ plaintiffs in the AFFF foam litigation.